René Fáber
Chief Executive Officer chez SARTORIUS STEDIM BIOTECH
Profil
René Fáber is currently the Chief Executive Officer & Director at Sartorius Stedim Biotech SA. He is also the Chairman at Sartorius Stédim FMT SAS, Director at Sartorius Stedim Japan KK, Director at Sartorius Korea Biotech Co., Ltd., Director at Sartorius Stedim (Shanghai) Trading Co., Ltd., Director at Albumedix Ltd., Director at Sartorius Korea Operations LLC, Director at Sartorius Stedim BioOutsource Ltd., Director at Sartorius Stedim Biotech (Beijing) Co., Ltd., and Head-Bioprocess Solutions Division at Sartorius AG.
Formerly, Dr. Fáber held positions such as Chairman-Supervisory Board at Sartorius Xell GmbH, Co-Managing Director & Member-Supervisory Board at Sartorius Stedim Biotech GmbH, Co-Managing Director at Sartorius Stedim North America Holding GmbH, Account Manager at Genentech, Inc., and Vice President-Marketing & Product Management at Filtration Technology Corp.Dr. Fáber obtained a doctorate degree from Technische Universität München and a graduate degree from Slovak University of Technology.
Postes actifs de René Fáber
| Sociétés | Poste | Début |
|---|---|---|
| SARTORIUS STEDIM BIOTECH | Chief Executive Officer | 28/03/2023 |
| SARTORIUS AG | Corporate Officer/Principal | 01/01/2019 |
Sartorius Stedim BioOutsource Ltd.
 Sartorius Stedim BioOutsource Ltd. Medical/Nursing ServicesHealth Services Part of Sartorius AG, Sartorius Stedim BioOutsource Ltd. is a British company that provides contract testing services of biologic drugs and vaccines. The private company is based in Glasgow, UK. The company was founded in 2007. The CEO is Hugo de Wit. Sartorius Stedim BioOutsource was acquired by Sartorius Stedim Biotech SA on April 17, 2015. | Director/Board Member | - |
Albumedix Ltd.
 Albumedix Ltd. BiotechnologyHealth Technology Part of Sartorius AG, Albumedix Ltd. is a British science-driven company and recognized leader of albumin-enabled solutions. The private company, based in Nottingham, UK, was founded in 1984 with a mission to empower excellence. Albumedix has supported its life-science partners in delivering safe doses of clinical and marketed therapeutics. The company's solutions include the world's only USP-NF compliant recombinant human albumin, client-centric development and compliance services, and drug-enhancing technologies. By challenging the status quo and striving for more, Albumedix enables the development and commercialization of advanced therapies and next-generation biopharmaceuticals. Albumedix is the world leader in recombinant human albumin and has developed a portfolio of products known as Recombumin®. Founded in 1973, the CEO of Albumedix is Jonas S. Moller. The company was acquired by Sartorius Stedim Biotech SA on September 30, 2022, for $500.47 million. | Director/Board Member | - |
| Sartorius Korea Operations LLC | Director/Board Member | - |
Sartorius Stédim FMT SAS
 Sartorius Stédim FMT SAS Containers/PackagingProcess Industries Sartorius Stedim Fmt SAS manufactures plastic packaging products. It serves to biopharmaceutical, chemical, food, and academic labs. The firm's product portfolio includes cell analysis, bioreactors, lab filtration, fluid management, and water purification. The company is headquartered in Aubagne, France. | Chairman | - |
| Sartorius Stedim (Shanghai) Trading Co., Ltd. | Director/Board Member | - |
| Sartorius Stedim Japan KK | Director/Board Member | - |
Sartorius Korea Biotech Co., Ltd.
 Sartorius Korea Biotech Co., Ltd. Engineering & ConstructionIndustrial Services Part of Sartorius AG, Sartorius Korea Biotech Co., Ltd. is a South Korean company that provides engineering services. The private company is based in Seongnam, South Korea. The company was founded in 2005. Duk-Sang Kim has been the CEO of the company since 2005. | Director/Board Member | - |
| ░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de René Fáber
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Formation de René Fáber
| Technische Universität München | Doctorate Degree |
| Slovak University of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SARTORIUS AG | Health Technology |
| SARTORIUS STEDIM BIOTECH | Health Technology |
| Entreprise privées | 13 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Sartorius Stedim Biotech GmbH
 Sartorius Stedim Biotech GmbH Medical SpecialtiesHealth Technology Part of Sartorius AG, Sartorius Stedim Biotech GmbH is a company based in Goettingen, Germany. The CEOs are Helge Henning, Michaela Pischke. The German company was founded in 2007. | Health Technology |
Filtration Technology Corp.
 Filtration Technology Corp. Oilfield Services/EquipmentIndustrial Services Filtration Technology Corp. manufactures oil and gas field machinery. The firm offers liquid filters for bag housings, including bag filters, pleated bag filters, and max-out conversion systems; liquid filters for cartridge housings, such as cartridge filters, pleated cartridge filters, and alternative replacement filters; and hydrocarbon removal filters, oil/water separation filter systems, and wastewater cleanup systems. It also provides technical services and support, and test and analysis services. The company was founded in 1987 and is headquartered in Houston, TX. | Industrial Services |
| Sartorius Stedim Japan KK | |
Sartorius Stedim BioOutsource Ltd.
Sartorius Stedim BioOutsource Ltd. Medical/Nursing ServicesHealth Services Part of Sartorius AG, Sartorius Stedim BioOutsource Ltd. is a British company that provides contract testing services of biologic drugs and vaccines. The private company is based in Glasgow, UK. The company was founded in 2007. The CEO is Hugo de Wit. Sartorius Stedim BioOutsource was acquired by Sartorius Stedim Biotech SA on April 17, 2015. | Health Services |
| Sartorius Stedim Biotech (Beijing) Co., Ltd. | |
Sartorius Korea Biotech Co., Ltd.
Sartorius Korea Biotech Co., Ltd. Engineering & ConstructionIndustrial Services Part of Sartorius AG, Sartorius Korea Biotech Co., Ltd. is a South Korean company that provides engineering services. The private company is based in Seongnam, South Korea. The company was founded in 2005. Duk-Sang Kim has been the CEO of the company since 2005. | Industrial Services |
Sartorius Stédim FMT SAS
Sartorius Stédim FMT SAS Containers/PackagingProcess Industries Sartorius Stedim Fmt SAS manufactures plastic packaging products. It serves to biopharmaceutical, chemical, food, and academic labs. The firm's product portfolio includes cell analysis, bioreactors, lab filtration, fluid management, and water purification. The company is headquartered in Aubagne, France. | Process Industries |
Albumedix Ltd.
Albumedix Ltd. BiotechnologyHealth Technology Part of Sartorius AG, Albumedix Ltd. is a British science-driven company and recognized leader of albumin-enabled solutions. The private company, based in Nottingham, UK, was founded in 1984 with a mission to empower excellence. Albumedix has supported its life-science partners in delivering safe doses of clinical and marketed therapeutics. The company's solutions include the world's only USP-NF compliant recombinant human albumin, client-centric development and compliance services, and drug-enhancing technologies. By challenging the status quo and striving for more, Albumedix enables the development and commercialization of advanced therapies and next-generation biopharmaceuticals. Albumedix is the world leader in recombinant human albumin and has developed a portfolio of products known as Recombumin®. Founded in 1973, the CEO of Albumedix is Jonas S. Moller. The company was acquired by Sartorius Stedim Biotech SA on September 30, 2022, for $500.47 million. | Health Technology |
Sartorius Stedim North America Holding GmbH
 Sartorius Stedim North America Holding GmbH Financial ConglomeratesFinance Part of Sartorius AG, Sartorius Stedim North America Holding GmbH provides financial services. The private company is based in Goettingen, Germany. The CEO of the German company is Uwe Becker. | Finance |
| Sartorius Korea Operations LLC | |
Sartorius Xell GmbH
 Sartorius Xell GmbH Pharmaceuticals: OtherHealth Technology Part of Sartorius AG, Sartorius Xell GmbH is a German company that specializes in providing solutions tailored to the specific requirements of cell lines, allowing them to achieve optimal product yields. The company, founded in 2009, is based in Schloß Holte-Stukenbrock, Germany. Xell's expertise lies in developing customized production processes, including cell culture media, feeds, and medical products. The private company's team of highly skilled and motivated employees, with diverse scientific backgrounds, emphasizes a strong focus on technology and innovation. Sartorius Xell was acquired by Sartorius Stedim Biotech SA on July 29, 2021. | Health Technology |
| Sartorius Stedim (Shanghai) Trading Co., Ltd. |
